跳至主要内容
临床试验/NCT06687590
NCT06687590招募中不适用

POst-Market ClINical Follow-up STudy oF the SerranatOR PTA Serration Balloon CathEter

Cagent Vascular LLC20 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2025年1月22日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
500
试验地点
20
主要终点
Performance Endpoint

研究概览

简要总结

The objective of this registry is to collect observational data under local standard of care and evaluate safety and performance of the Serranator® in treatment of peripheral artery disease (PAD), or dysfunctional native or synthetic arteriovenous dialysis fistulae in a real-world scenario.

The data and conclusions derived from this study will be used to provide clinical evidence for the clinical evaluation process.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects intended to be treated with Serranator® for de-novo or restenotic lesions of the iliac, femoral, iliofemoral, popliteal, infrapopliteal and pedal arteries or dysfunctional native or synthetic arteriovenous dialysis fistulae.
  • Subjects presenting with claudication or critical limb-threatening ischemia (CLTI) by Rutherford Clinical Category 3, 4, 5, or 6 of the target limb.
  • Age of subject is >
  • Subject or subject's legal representative has been informed of the nature of the study, agrees to participate and has signed the approved consent form.

排除标准

  • Subjects with any medical condition that would make him/her an inappropriate candidate for treatment with Serranator® as per Instructions for Use (IFU) or investigator's opinion.
  • Subject already enrolled in other investigational (interventional) studies that would interfere with study endpoints.

结局指标

主要结局

Performance Endpoint

时间窗: Peri-procedural

Device Success defined as the achievement of successful delivery, balloon inflation and deflation, and retrieval of the study device(s) with a post- Serranator® residual stenosis of ≤30% by angiographic core laboratory assessment at the intended target lesion.

次要结局

  • Safety Endpoint(Peri-procedural)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (20)

Loading locations...

相似试验